5-hydroxymethylcytosine has been researched along with Medulloblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Allen, EG; Barwick, BG; Castellino, RC; Chen, J; Chen, L; Conneely, KN; Jin, P; Johnson, ND; Kang, Y; Kenney, AM; Kim, H; Li, J; Li, Y; Liao, X; Lin, L; McSwain, L; Robinson, MH; Shu, Q; Van Meir, EG; Vertino, PM; Yuan, X; Zhang, Z; Zhao, J; Zhu, D | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Medulloblastoma
Article | Year |
---|---|
Ten-eleven translocation protein 1 modulates medulloblastoma progression.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Computational Biology; CpG Islands; Databases, Nucleic Acid; Disease Models, Animal; Disease Progression; Disease Susceptibility; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Mice; Mice, Transgenic; Mixed Function Oxygenases; Nucleotide Motifs; Prognosis; Proto-Oncogene Proteins | 2021 |